• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity
• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity
• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity
Research Disclaimer: This article is for educational and informational purposes only. All compounds discussed are sold strictly as research chemicals and are not intended for human consumption, therapeutic use, or self-administration.

Introduction: Synaptic Growth vs Cellular Energy

Dihexa and NAD+ address cognitive decline from opposite ends of the neuroscience spectrum. Dihexa creates new synaptic connections by potentiating HGF/c-Met neurotrophic signaling at picomolar concentrations — essentially building new neural architecture. NAD+ fuels the existing neural machinery by supporting mitochondrial energy production, sirtuin-mediated neuroprotection, and DNA repair — keeping neurons alive and functional.

One builds new connections (Dihexa); the other prevents existing neurons from failing (NAD+). Neither is our product, but understanding their mechanisms helps researchers contextualize peptide-based approaches like Semax (BDNF-mediated) within the broader neuroprotection landscape.

Dihexa: Ultra-Potent Synaptogenic Agent

Dihexa (N-hexanoic-Tyr-Ile-(6)aminohexanoic amide) is an angiotensin IV analog that potentiates HGF signaling at the c-Met receptor. At picomolar concentrations, it promotes new dendritic spine and synapse formation in hippocampal neurons. In aged rats, Dihexa restored learning and memory to young-animal levels (PMID: 23055539). Orally bioavailable and BBB-penetrant.

NAD+: The Universal Energy Coenzyme

NAD+ (nicotinamide adenine dinucleotide) is required for mitochondrial oxidative phosphorylation, sirtuin deacetylase activity (SIRT1, SIRT3), and PARP-mediated DNA repair. Brain NAD+ declines ~50% with aging, contributing to neuronal energy failure. Boosted through precursors NMN and NR.

Mechanism Comparison

FeatureDihexaNAD+
ClassPeptidomimetic (AngIV analog)Coenzyme (dinucleotide)
TargetHGF/c-Met ? synaptogenesisMitochondria/sirtuins/PARP
PotencyPicomolar (extremely potent)Physiological concentrations
Cognitive EffectStructural (new synapses)Metabolic (better energy)
Systemic EffectsBrain-focusedEvery cell in the body
Safety DataVery limitedExtensive (essential metabolite)

Choosing the Right Compound

Choose Dihexa when: Synaptogenesis, cognitive restoration in aging, and HGF/c-Met biology are the research focus. Exercise extreme dose caution due to picomolar potency.

Choose NAD+ when: Mitochondrial function, neuronal energy metabolism, sirtuin biology, or DNA repair are endpoints. Well-characterized safety profile.

For peptide-based brain research, Semax offers a clinically-validated middle ground — BDNF upregulation for cognitive enhancement with an established safety profile from Russian clinical use.

Frequently Asked Questions

Is Dihexa better than NAD+ for memory?

Dihexa has more dramatic preclinical cognitive restoration data (restoring aged rat memory to young levels), but with very limited safety data. NAD+ improvement of brain function is more modest but supported by extensive metabolic research and safety data. Dihexa creates new synapses; NAD+ improves the energy supply to existing ones. For a peptide-based nootropic with clinical safety data, consider Semax.

Can Dihexa and NAD+ be combined?

They target non-overlapping pathways. A combination could theoretically provide both new synaptic connections (Dihexa) and improved energy supply to support those connections (NAD+). However, Dihexa’s limited safety data and extreme potency warrant caution in any combination protocol.

References

  1. McCoy AT, et al. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. J Pharmacol Exp Ther. 2013;344(1):141-154. PMID: 23055539
  2. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471.
  3. Wang X, et al. Nicotinamide mononucleotide protects against ?-amyloid oligomer-induced cognitive impairment. Brain Res. 2016;1643:1-9.

About Proxiva Labs: For peptide-based cognitive research, we supply Semax (BDNF-mediated nootropic) and BPC-157 (neuroprotective tissue repair). For metabolic peptide research: MOTS-c. Browse the complete research peptide catalog.


All products are sold strictly for research purposes only. Not for human consumption.

📦 USA Manufacturing ✅ 99.99% Purity 📦 Free Shipping $150+

Related Articles

0
    0
    Your Cart
    Your cart is emptyReturn to Shop